Regístrese
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Most Often Read Most Often Read
Journal Information

Most Often Read

814
Current concepts in acute liver failure
Maximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
814
Open access
698
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)
Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller
Ann Hepatol. 2019;18:518-35
698
Open access
549
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
Sebastião M.B. Duarte, Jose Tadeu Stefano, Claudia P. Oliveira
Ann Hepatol. 2019;18:416-21
549
Open access
509
Endoscopic retrograde cholangiopancreatography versus surgery for choledocholithiasis – A meta-analysis
Fernando C. Schacher, Sofia M. Giongo, Fernanda J.P. Teixeira, Ângelo Z. Mattos
Ann Hepatol. 2019;18:595-600
509
Open access
433
Liver disease in pregnancy: Medical aspects and their implications for mother and child
Carmen Selene García-Romero, Carolina Guzman, Alicia Cervantes, Marco Cerbón
Ann Hepatol. 2019;18:553-62
433
Open access
371
Hepatitis E and chronic liver damage in apparently immunocompetent individuals: Now what?
Santiago Mirazo, Juan Arbiza
Ann Hepatol. 2019;18:539-40
371
Open access
344
Antioxidants benefits in hepatitis C infection in the new DAAs era
Sonia A. Lozano-Sepúlveda, Ana R. Rincón-Sanchez, Ana M. Rivas-Estilla
Ann Hepatol. 2019;18:410-5
344
Open access
326
First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in Mexico
Oliver Viera-Segura, Mauricio Realpe-Quintero, Arturo Panduro, Sonia Roman, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Jorge L. Trujillo-Ochoa, Nora A. Fierro
Ann Hepatol. 2019;18:571-7
326
Open access
312
Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes
Abdulrahman A. Aljumah, Hamad Al-Ashgar, Hind Fallatah, Ali Albenmousa
Ann Hepatol. 2019;18:439-44
312
Open access
294
Hepatitis E in Latin America
Rosa Elena Sarmiento-Silva, Francisco Arenas-Huertero
Ann Hepatol. 2019;18:541-2
294
Open access
277
The basis of liver regeneration: A systems biology approach
Mamatha Bhat, Elisa Pasini, Cristina Baciu, Marc Angeli, Atul Humar, Sonya Macparland, Jordan Feld, Ian McGilvray
Ann Hepatol. 2019;18:422-8
277
Open access
271
Genome-based nutritional strategies to prevent chronic liver disease
Sonia Roman
Ann Hepatol. 2019;18:537-8
271
Open access
269
Non-alcoholic fatty liver disease and neurological defects
Rita Moretti, Paola Caruso, Silvia Gazzin
Ann Hepatol. 2019;18:563-70
269
Open access
268
Why, What and Where: 3W in hepatology
Claudio Tiribelli
Ann Hepatol. 2019;18:409
268
Open access
266
Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
Cristiane V. Tovo, Cristiane A. Villela-Nogueira, Nathalie C. Leite, Carine L. Panke, Gabriela Z. Port, Sabrina Fernandes, Caroline Buss, Gabriela P. Coral, Ana C. Cardoso, Claudia M. Cravo, Fernanda L. Calçado, Guilherme F.M. Rezende, Frederico C. Ferreira, João M. Araujo-Neto, Renata de M. Perez, Henrique S. Moraes-Coelho, Angelo A. de Mattos
Ann Hepatol. 2019;18:445-9
266
Open access
246
Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
Alejandra Cano-Paniagua, Pedro Amariles, Nancy Angulo, Margarita Restrepo-Garay
Ann Hepatol. 2019;18:501-7
246
Open access
244
Vasoconstrictors in hepatorenal syndrome – A critical review
Ângelo Z. Mattos, Fernando C. Schacher, Angelo A. Mattos
Ann Hepatol. 2019;18:287-90
244
Open access
239
Treatment response in primary biliary cholangitis: The role of autoimmune hepatitis features
Fernando Mané, Hélder Cardoso, Rodrigo Liberal, Susana Lopes, Pedro Pereira, Regina Gonçalves, Guilherme Macedo
Ann Hepatol. 2019;18:488-93
239
Open access
238
The relationship between coagulation disorders and the risk of bleeding in cirrhotic patients
Asma Labidi, Héla Baccouche, Monia Fekih, Sonia Mahjoub, Nadia BenMustapha, Meriem Serghini, Neila BenRomdhane, Jalel Boubaker
Ann Hepatol. 2019;18:627-32
238
Open access
236
Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?
Filiz Akyüz, Bilger Çavuş, Binnur Pınarbaşı, Mürvet Bozacı, Bülent Baran, Umit Akyuz, Ahmet Uyanıkoglu, Kadir Demir, Fatih Beşışık, Sadakat Özdil, Güngör Boztaş, Zeynel Mungan, Selim Badur, Sadi Yenen, Sabahattin Kaymakoglu
Ann Hepatol. 2019;18:585-9
236
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.